Table 2. - Main multiresistant bacteria isolated in clinical samples from cirrhotic patients according to the type of biological sample.
Bacteria | Blood | Respiratory secretions | Urine | Ascitic fluid | Other abdominal collections |
Total multiresistant bacteria | 64/166 | 15/52 | 69/188 | 25/51 | 1/7 |
ESBL-producing E. coli and Klebsiella sp. | 11/55 | 0/9 | 25/119 | 6/20 | 0/3 |
Methicillin-resistant S. aureus | 14/36 | 4/10 | 3/6 | 6/9 | -/- |
Vancomycin-resistant E. faecium | 5/8 | -/- | 1/1 | 1/1 | -/- |
Vancomycin-resistant E. faecalis | 0/5 | -/- | -/- | 0/1 | 0/2 |
Multiresistant Acinetobacter sp. | 4/6 | 4/4 | 1/1 | 1/1 | -/- |
Multiresistant P. aeruginosa | 3/3 | 3/6 | -/- | 1/3 | -/- |
S. maltophilia | 4/4 | -/- | -/- | -/- | -/- |
A. xylosoxidans | 1/1 | -/- | -/- | 2/2 | -/- |
B. cepacia | -/- | -/- | -/- | -/- | -/- |
Data are presented as the number of resistant isolates by the total number of isolates. ESBL: extended spectrum beta-lactamases.